FIELD: medicine, pharmaceutics.
SUBSTANCE: invention refers to a compound presented by formula (E) , wherein X, Y and L are independently non-directionally specified in -C(R1)(R2)-, -C(R3)=, -N(R4)-, -N= and -O-; M and Z are independently non-directionally specified in ; ---- means an optional double bond; R1, R2, R3, R4 and R6 are independently specified in hydrogen; C1-4 alkyl; group -C1-4 alkylene-halogen; group -C1-4 alkylene-OH; Hal is specified in F, Cl, Br and I; RE1 and RE2 are attached to neighbouring carbon atoms, and RE1 and RE2 together non-directionally form the structure -T-(CRE7RE8)n-V-, wherein T is specified in CRE9RE10 and O or NH, and V is specified in CRE9RE10 and O or NH, as well as respective structures comprising a double bond; at least one of T or V represents O or N; RE7 and RE8 represent H or F; RE9 and RE10 represent H; n takes on the values of 1 to 2; RE3 represents C1-6 alkyl group; m takes on the values of 0 or 1; RE4 represents a halogen atom; p takes on the values of 0 or 1; as well as to pharmaceutical diagnostic compositions of the above compound.
EFFECT: preparing the new pharmaceutical compounds.
41 cl, 17 dwg, 2 tbl, 17 ex
Title | Year | Author | Number |
---|---|---|---|
WATER-SOLUBLE DERIVATIVES OF 3,5-DIPHENYLDIAZOLE COMPOUNDS | 2016 |
|
RU2764131C2 |
NEW COMPOUNDS FOR TREATING AMYLOID OR AMYLOID-LIKE PROTEIN ASSOCIATED DISEASES | 2007 |
|
RU2469026C2 |
NEW COMPOUNDS FOR TREATING DISEASES, ASSOCIATED WITH AMYLOID OR AMYLOID-LIKE PROTEINS | 2011 |
|
RU2603008C2 |
2,6-DIAMINOPYRIDINE COMPOUNDS FOR TREATING AMYLOID PROTEIN RELATED PROTEINS AND FOR TREATING OCULAR DISEASES | 2010 |
|
RU2538208C2 |
DETECTION METHOD OF PROTEINS IN AMYLOID STATE, AND SET FOR DETECTION OF PROTEINS IN AMYLOID STATE | 2012 |
|
RU2509155C1 |
NOVEL COMPOUNDS FOR DIAGNOSING, TREATING AND PREVENTING DISEASES ASSOCIATED WITH ALPHA-SYNUCLEIN AGGREGATION | 2020 |
|
RU2822486C1 |
FUSED MOLECULE CAPABLE OF INDUCING NON-INFLAMMATORY PHAGOCYTOSIS | 2022 |
|
RU2823919C1 |
COMPOUNDS, COMPOSITIONS AND METHODS FOR TREATING BETA-AMYLOID DISEASES AND SYNUCLEINOPATHIES | 2009 |
|
RU2501792C2 |
2-(R-THIO)-10-[3-(4-R-PIPERAZINE-1-YL)PROPYL]-10H-PHENOTHIAZINE FOR TREATING A BETA-AMYLOIDOSES OR ALPHA-SYNUCLEOPATHY AND METHOD FOR DIAGNOSIS OR PREDIAGNOSIS THEREOF | 2011 |
|
RU2587154C2 |
LIFE PROLONGATION PRACTICES FOR PRION PATIENTS | 2005 |
|
RU2353379C2 |
Authors
Dates
2014-10-27—Published
2009-06-09—Filed